Description

Insulin Novorapid is a modern insulin solution designed to mimic the body’s natural insulin response. It contains insulin aspart, a rapid-acting insulin analogue that helps regulate blood sugar levels after meals. The pre-filled pens are convenient and simple to use, ensuring accurate dosing with each injection. This product is particularly beneficial for individuals with type 1 or type 2 diabetes who require flexible insulin management.

The fast-acting nature of Insulin Novorapid makes it an excellent choice for controlling post-meal glucose levels. It can be used in combination with long-acting insulin or insulin pumps for optimal diabetes management. The pens are designed for portability and ease of use, making them ideal for those with active lifestyles. Always consult your healthcare provider to determine the correct dosage and administration schedule for your needs.

Ingredients

• Insulin aspart (100 units/ml)
• Glycerol
• Phenol
• Metacresol
• Zinc chloride
• Disodium phosphate dihydrate
• Sodium chloride
• Hydrochloric acid (for pH adjustment)
• Sodium hydroxide (for pH adjustment)
• Water for injections

Instructions for Use

• Wash your hands thoroughly before handling the pen.
• Check the insulin for clarity; it should be clear and colourless. Do not use if cloudy or discoloured.
• Attach a new needle to the pen and prime it by dialling 2 units and pressing the plunger until insulin appears at the needle tip.
• Dial your prescribed dose using the dose selector.
• Inject subcutaneously into the abdomen, thigh, or upper arm. Rotate injection sites to avoid lipodystrophy.
• After injection, leave the needle in place for at least 6 seconds to ensure the full dose is delivered.
• Dispose of the needle safely after each use. Do not share pens or needles.

Potential Side Effects

• Hypoglycaemia (low blood sugar)
• Injection site reactions (redness, swelling, or itching)
• Allergic reactions (rash, difficulty breathing, or swelling of the face and throat)
• Lipodystrophy (thickening or thinning of the skin at injection sites)
• Oedema (swelling caused by fluid retention)
• Vision changes (usually temporary)